Wa Of Great Neck North

PFAS monitoring results for a public water system in New York

NY2902841UCMR 5EPA monitoring data
<MRLHighest PFOA result, ppt
<MRLHighest PFOS result, ppt
0Highest Hazard Index
455Results
PWSID
NY2902841
State
New York
System type
community water system (CWS)
Population served
31,400
City
Great Neck
Counties
Nassau County
Primary source water
groundwater
UCMR 5 sampling
2023-09-20 to 2024-09-18 · 8 entry point(s) · water types: GW
Service-area boundary
authoritative

No PFAS detected highest single result
No PFAS detected worst entry-point average

These are monitoring results collected under EPA's Fifth Unregulated Contaminant Monitoring Rule (UCMR 5) at entry points, where treated water enters the distribution system; they are not tap-water samples. They are not compliance determinations: compliance with EPA's 2024 PFAS limits is judged on running annual averages of compliance monitoring, required from 2029, so a single UCMR 5 result at or above a limit is not a violation. “< MRL” means the compound was not quantified at EPA's minimum reporting level; it does not mean zero.

Compared with EPA's 2024 values

Highest single resultWorst entry-point average*Limit
PFOA (ppt)<MRL04
PFOS (ppt)<MRL04
Hazard Index001.0†

“<MRL” = every result for the compound was below its reporting limit. * Mean of all samples at each entry point with non-detects = 0 (EPA compliance convention; the Hazard Index also uses non-detects = 0); a screening comparison, not a formal running annual average. † Rescission proposed May 2026. PFOA/PFOS MCL 4 ppt (2024 NPDWR, in effect). PFHxS, PFNA, HFPO-DA (10 ppt each) and the Hazard Index (1.0) are 2024 NPDWR values; EPA proposed rescinding them on 18 May 2026 (comment period closed 20 Jul 2026).

Compared with New York standards

Highest single resultWorst entry-point average*New York
PFOA (ppt)0010
PFOS (ppt)0010

Sum standards add the listed compounds within each sample (non-detects = 0). State compliance is normally judged on averages over time; these are screening comparisons.

Sampling history

Sampled 2023-09-20 to 2024-09-18 · 8 entry point(s) · water types: GW · 25 sampling visits. PFAS in ppt (ng/L).

DateEntry pointEventPFOAPFOSHIOther detections
2023-09-20Well 10A Treatment (GW)SE1<4<40none
2023-09-20Well 11A Treatment (GW)SE1<4<40none
2023-09-20Well 5 Treatment (GW)SE1<4<40none
2023-09-20Well 6 Treatment (GW)SE1<4<40none
2023-09-20Well 7 Treatment (GW)SE1<4<40none
2023-09-20Wells 12,13,& 14 Treatment (GW)SE1<4<40none
2023-09-20Wells 2A & 9 Treatment (GW)SE1<4<40none
2023-10-18Well 10A Treatment (GW)SE1n/an/an/anone
2023-10-18Well 11A Treatment (GW)SE1n/an/an/anone
2023-10-18Well 5 Treatment (GW)SE1n/an/an/anone
2023-10-18Well 6 Treatment (GW)SE1n/an/an/anone
2023-10-18Well 7 Treatment (GW)SE1n/an/an/anone
2023-10-18Wells 12,13,& 14 Treatment (GW)SE1n/an/an/anone
2023-10-18Wells 2A & 9 Treatment (GW)SE1n/an/an/anone
2024-03-11Well 8 Treatment (GW)SE1<4<40none
2024-04-23Well 11A Treatment (GW)SE2n/an/an/anone
2024-04-23Well 5 Treatment (GW)SE2<4<40none
2024-04-23Well 6 Treatment (GW)SE2<4<40none
2024-04-23Well 7 Treatment (GW)SE2<4<40none
2024-04-23Wells 12,13,& 14 Treatment (GW)SE2n/an/an/anone
2024-04-23Wells 2A & 9 Treatment (GW)SE2n/an/an/anone
2024-05-21Wells 2A & 9 Treatment (GW)SE2<4<40none
2024-05-29Wells 12,13,& 14 Treatment (GW)SE2<4<40none
2024-09-18Well 10A Treatment (GW)SE2<4<40none
2024-09-18Well 8 Treatment (GW)SE2<4<40none

“<4” = not detected at the reporting limit shown; “n/a” = not analyzed in that sample. Highlighted = at or above the 4 ppt MCL. HI computed per sample with non-detects as 0. Other detections lists every other quantified compound (lithium in µg/L).

All results by entry point

455 results. Each column is one sampling visit (date and UCMR 5 sample event). A number is a measured concentration; “< 4” = below the minimum reporting level shown; “–” = not analyzed in that visit. PFAS in ppt (ng/L); lithium in µg/L.

Well 10A Treatment facility 12735 · sample point T12735 · groundwater

CompoundMRL2023-09-20
SE1
2023-10-18
SE1
2024-09-18
SE2
11Cl-PF3OUdS5 ppt< 5–< 5
4:2 FTS3 ppt< 3–< 3
6:2 FTS5 ppt< 5–< 5
8:2 FTS5 ppt< 5–< 5
9Cl-PF3ONS2 ppt< 2–< 2
ADONA3 ppt< 3–< 3
HFPO-DA5 ppt< 5–< 5
NEtFOSAA5 ppt–< 5< 5
NFDHA20 ppt< 20–< 20
NMeFOSAA6 ppt–< 6< 6
PFBA5 ppt< 5–< 5
PFBS3 ppt< 3–< 3
PFDA3 ppt< 3–< 3
PFDoA3 ppt< 3–< 3
PFEESA3 ppt< 3–< 3
PFHpA3 ppt< 3–< 3
PFHpS3 ppt< 3–< 3
PFHxA3 ppt< 3–< 3
PFHxS3 ppt< 3–< 3
PFMBA3 ppt< 3–< 3
PFMPA4 ppt< 4–< 4
PFNA4 ppt< 4–< 4
PFOA4 ppt< 4–< 4
PFOS4 ppt< 4–< 4
PFPeA3 ppt< 3–< 3
PFPeS4 ppt< 4–< 4
PFTA8 ppt–< 8< 8
PFTrDA7 ppt–< 7< 7
PFUnA2 ppt< 2–< 2
lithium9 µg/L< 9–< 9

Well 11A Treatment facility 01425 · sample point T014250 · groundwater

CompoundMRL2023-09-20
SE1
2023-10-18
SE1
2024-04-23
SE2
11Cl-PF3OUdS5 ppt< 5––
4:2 FTS3 ppt< 3––
6:2 FTS5 ppt< 5––
8:2 FTS5 ppt< 5––
9Cl-PF3ONS2 ppt< 2––
ADONA3 ppt< 3––
HFPO-DA5 ppt< 5––
NEtFOSAA5 ppt–< 5< 5
NFDHA20 ppt< 20––
NMeFOSAA6 ppt–< 6< 6
PFBA5 ppt< 5––
PFBS3 ppt< 3––
PFDA3 ppt< 3––
PFDoA3 ppt< 3––
PFEESA3 ppt< 3––
PFHpA3 ppt< 3––
PFHpS3 ppt< 3––
PFHxA3 ppt< 3––
PFHxS3 ppt< 3––
PFMBA3 ppt< 3––
PFMPA4 ppt< 4––
PFNA4 ppt< 4––
PFOA4 ppt< 4––
PFOS4 ppt< 4––
PFPeA3 ppt< 3––
PFPeS4 ppt< 4––
PFTA8 ppt–< 8< 8
PFTrDA7 ppt–< 7< 7
PFUnA2 ppt< 2––
lithium9 µg/L< 9–< 9

Well 5 Treatment facility 00687 · sample point T00687 · groundwater

CompoundMRL2023-09-20
SE1
2023-10-18
SE1
2024-04-23
SE2
11Cl-PF3OUdS5 ppt< 5–< 5
4:2 FTS3 ppt< 3–< 3
6:2 FTS5 ppt< 5–< 5
8:2 FTS5 ppt< 5–< 5
9Cl-PF3ONS2 ppt< 2–< 2
ADONA3 ppt< 3–< 3
HFPO-DA5 ppt< 5–< 5
NEtFOSAA5 ppt–< 5< 5
NFDHA20 ppt< 20–< 20
NMeFOSAA6 ppt–< 6< 6
PFBA5 ppt< 5–< 5
PFBS3 ppt< 3–< 3
PFDA3 ppt< 3–< 3
PFDoA3 ppt< 3–< 3
PFEESA3 ppt< 3–< 3
PFHpA3 ppt< 3–< 3
PFHpS3 ppt< 3–< 3
PFHxA3 ppt< 3–< 3
PFHxS3 ppt< 3–< 3
PFMBA3 ppt< 3–< 3
PFMPA4 ppt< 4–< 4
PFNA4 ppt< 4–< 4
PFOA4 ppt< 4–< 4
PFOS4 ppt< 4–< 4
PFPeA3 ppt< 3–< 3
PFPeS4 ppt< 4–< 4
PFTA8 ppt–< 8< 8
PFTrDA7 ppt–< 7< 7
PFUnA2 ppt< 2–< 2
lithium9 µg/L< 9–< 9

Well 6 Treatment facility 01298 · sample point AS01298 · groundwater

CompoundMRL2023-09-20
SE1
2023-10-18
SE1
2024-04-23
SE2
11Cl-PF3OUdS5 ppt< 5–< 5
4:2 FTS3 ppt< 3–< 3
6:2 FTS5 ppt< 5–< 5
8:2 FTS5 ppt< 5–< 5
9Cl-PF3ONS2 ppt< 2–< 2
ADONA3 ppt< 3–< 3
HFPO-DA5 ppt< 5–< 5
NEtFOSAA5 ppt–< 5< 5
NFDHA20 ppt< 20–< 20
NMeFOSAA6 ppt–< 6< 6
PFBA5 ppt< 5–< 5
PFBS3 ppt< 3–< 3
PFDA3 ppt< 3–< 3
PFDoA3 ppt< 3–< 3
PFEESA3 ppt< 3–< 3
PFHpA3 ppt< 3–< 3
PFHpS3 ppt< 3–< 3
PFHxA3 ppt< 3–< 3
PFHxS3 ppt< 3–< 3
PFMBA3 ppt< 3–< 3
PFMPA4 ppt< 4–< 4
PFNA4 ppt< 4–< 4
PFOA4 ppt< 4–< 4
PFOS4 ppt< 4–< 4
PFPeA3 ppt< 3–< 3
PFPeS4 ppt< 4–< 4
PFTA8 ppt–< 8< 8
PFTrDA7 ppt–< 7< 7
PFUnA2 ppt< 2–< 2
lithium9 µg/L< 9–< 9

Well 7 Treatment facility 02214 · sample point T02214 · groundwater

CompoundMRL2023-09-20
SE1
2023-10-18
SE1
2024-04-23
SE2
11Cl-PF3OUdS5 ppt< 5–< 5
4:2 FTS3 ppt< 3–< 3
6:2 FTS5 ppt< 5–< 5
8:2 FTS5 ppt< 5–< 5
9Cl-PF3ONS2 ppt< 2–< 2
ADONA3 ppt< 3–< 3
HFPO-DA5 ppt< 5–< 5
NEtFOSAA5 ppt–< 5< 5
NFDHA20 ppt< 20–< 20
NMeFOSAA6 ppt–< 6< 6
PFBA5 ppt< 5–< 5
PFBS3 ppt< 3–< 3
PFDA3 ppt< 3–< 3
PFDoA3 ppt< 3–< 3
PFEESA3 ppt< 3–< 3
PFHpA3 ppt< 3–< 3
PFHpS3 ppt< 3–< 3
PFHxA3 ppt< 3–< 3
PFHxS3 ppt< 3–< 3
PFMBA3 ppt< 3–< 3
PFMPA4 ppt< 4–< 4
PFNA4 ppt< 4–< 4
PFOA4 ppt< 4–< 4
PFOS4 ppt< 4–< 4
PFPeA3 ppt< 3–< 3
PFPeS4 ppt< 4–< 4
PFTA8 ppt–< 8< 8
PFTrDA7 ppt–< 7< 7
PFUnA2 ppt< 2–< 2
lithium9 µg/L< 9–< 9

Well 8 Treatment facility 03443 · sample point AS03443 · groundwater

CompoundMRL2024-03-11
SE1
2024-09-18
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L< 9< 9

Wells 12,13,& 14 Treatment facility 13821 · sample point AS012013014 · groundwater

CompoundMRL2023-09-20
SE1
2023-10-18
SE1
2024-04-23
SE2
2024-05-29
SE2
11Cl-PF3OUdS5 ppt< 5––< 5
4:2 FTS3 ppt< 3––< 3
6:2 FTS5 ppt< 5––< 5
8:2 FTS5 ppt< 5––< 5
9Cl-PF3ONS2 ppt< 2––< 2
ADONA3 ppt< 3––< 3
HFPO-DA5 ppt< 5––< 5
NEtFOSAA5 ppt–< 5< 5–
NFDHA20 ppt< 20––< 20
NMeFOSAA6 ppt–< 6< 6–
PFBA5 ppt< 5––< 5
PFBS3 ppt< 3––< 3
PFDA3 ppt< 3––< 3
PFDoA3 ppt< 3––< 3
PFEESA3 ppt< 3––< 3
PFHpA3 ppt< 3––< 3
PFHpS3 ppt< 3––< 3
PFHxA3 ppt< 3––< 3
PFHxS3 ppt< 3––< 3
PFMBA3 ppt< 3––< 3
PFMPA4 ppt< 4––< 4
PFNA4 ppt< 4––< 4
PFOA4 ppt< 4––< 4
PFOS4 ppt< 4––< 4
PFPeA3 ppt< 3––< 3
PFPeS4 ppt< 4––< 4
PFTA8 ppt–< 8< 8–
PFTrDA7 ppt–< 7< 7–
PFUnA2 ppt< 2––< 2
lithium9 µg/L< 9–< 9–

Wells 2A & 9 Treatment facility 12796 · sample point AS02A09 · groundwater

CompoundMRL2023-09-20
SE1
2023-10-18
SE1
2024-04-23
SE2
2024-05-21
SE2
11Cl-PF3OUdS5 ppt< 5––< 5
4:2 FTS3 ppt< 3––< 3
6:2 FTS5 ppt< 5––< 5
8:2 FTS5 ppt< 5––< 5
9Cl-PF3ONS2 ppt< 2––< 2
ADONA3 ppt< 3––< 3
HFPO-DA5 ppt< 5––< 5
NEtFOSAA5 ppt–< 5< 5–
NFDHA20 ppt< 20––< 20
NMeFOSAA6 ppt–< 6< 6–
PFBA5 ppt< 5––< 5
PFBS3 ppt< 3––< 3
PFDA3 ppt< 3––< 3
PFDoA3 ppt< 3––< 3
PFEESA3 ppt< 3––< 3
PFHpA3 ppt< 3––< 3
PFHpS3 ppt< 3––< 3
PFHxA3 ppt< 3––< 3
PFHxS3 ppt< 3––< 3
PFMBA3 ppt< 3––< 3
PFMPA4 ppt< 4––< 4
PFNA4 ppt< 4––< 4
PFOA4 ppt< 4––< 4
PFOS4 ppt< 4––< 4
PFPeA3 ppt< 3––< 3
PFPeS4 ppt< 4––< 4
PFTA8 ppt–< 8< 8–
PFTrDA7 ppt–< 7< 7–
PFUnA2 ppt< 2––< 2
lithium9 µg/L< 9–< 9–

Statistics by compound

No compound was detected; every result is below its reporting limit, so no Kaplan–Meier statistics can be estimated.

Never detected (30): 11Cl-PF3OUdS, 4:2 FTS, 6:2 FTS, 8:2 FTS, 9Cl-PF3ONS, ADONA, HFPO-DA, NEtFOSAA, NFDHA, NMeFOSAA, PFBA, PFBS, PFDA, PFDoA, PFEESA, PFHpA, PFHpS, PFHxA, PFHxS, PFMBA, PFMPA, PFNA, PFOA, PFOS, PFPeA, PFPeS, PFTA, PFTrDA, PFUnA, lithium.

Left-censored Kaplan–Meier statistics (Helsel 2005; Helsel & Lee 2006, NADA for R). Units: ppt; lithium µg/L. Each compound has one reporting limit, so the Kaplan–Meier mean equals the upper mean bound (non-detects at the MRL); the lower bound sets non-detects to 0. “<MRL” = the percentile falls below the reporting limit and cannot be estimated. These describe this system's UCMR 5 samples, not population estimates.

Sources

  • EPA UCMR 5 occurrence data text files (UCMR5_All.txt; samples 2023-01-03 to 2026-06-17; data summary dated Jul 2026)
  • EPA SDWIS via ECHO SDWA downloads, quarter 2026Q3
  • EPA Public Water System Service Areas v3 (Mar 2026)
  • US Census Bureau cartographic boundary counties 1:500k, 2024
  • EPA/USGS NHDPlus V2 (medium resolution) flowlines, Strahler order 2+

Data build 171ad949e257 · 2026-10-18T04:10Z · UCMR 5 release Jul2026 · SDWIS 2026Q3. Data and methods.